alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Lianyun Han, Chief Executive Officer of
SHUAIYI INTERNATIONAL NEW RESOURCES DEVELOPMENT INC. (the Company), DOES
HEREBY CERTIFY that:

1.

The Companys Quarterly Report on Form 10-Q for the quarter ended September 30,
2009 (the Report), fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and

2.

Information contained in the Report fairly presents, in all material respects,
the financial condition and results of operation of the Company.

IN WITNESS WHEREOF, each of the undersigned has executed this
statement this 12th day of November 2009.

| | /s/ Lianyun
      Han        
| | -----------------------------
| | Lianyun Han                  
| | Chief Executive Officer      
| | (Principal Executive Officer)

A signed original of this written statement required by Section
906 has been provided to Shuaiyi International New Resources Development Inc.
and will be retained by Shuaiyi International New Resources Development Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

The forgoing certification is being furnished to the Securities
and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, and is not to be incorporated by reference into any filing of the
Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.

---
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4975 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 4975

 To suspend temporarily the duty on perfluorobutane sulfonyl fluoride.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 15, 2008

 Mr. Ramstad introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on perfluorobutane sulfonyl fluoride.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERFLUOROBUTANE SULFONYL FLUORIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00      Perfluorobutane     Free         No change        No change        On or before 12/  ''.
                         sulfonyl fluoride                                                  31/2011
                         (CAS No. 375-72-
                         4) (provided for
                         in subheading
                         2904.10.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
**Exhibit 32**
 
 **CERTIFICATION PURSUANT TO**
 **18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**
 **SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**
 
 In connection with the Quarterly Report of Bristol West Holdings, Inc. (the "Company") on Form 10-Q for the period ending September 30, 2004, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, James R. Fisher and Craig E. Eisenacher, Chief Executive Officer and Chief Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:
 
 (1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
 (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 November 11, 2004
 
 /s/  JAMES R. FISHER

/s/  CRAIG E. EISENACHERJames R. Fisher

Craig E. EisenacherChairman and Chief Executive Officer

Senior Vice President and Chief Financial Officer
EXHIBIT
        32.2
 
 **CERTIFICATION
        OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER**
 **PURSUANT
        TO SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
        2002**
 
 Pursuant
        to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
        Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly
        Report on Form 10-Q for the fiscal year ended March 31, 2008 (the “Report”) by
        China Fire & Security Group, Inc. (the “Registrant”), I, Brian Lin, hereby
        certify that:
 
 1.
        To the
        best of my knowledge, the Report fully complies with the requirements of
        Section
        13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 2.
        To the
        best of my knowledge, the information contained in the Report fairly presents,
        in all material respects, the financial condition and results of operations
        of
        the Registrant.
 Dated:
                  May 15, 2008
              By:
              /s/
                  Brian LinName: Brian
                  LinTitle:  
                  Principal Accounting Officer
Exhibit
      32.2




**CERTIFICATIONS
      PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**


**(18
      U.S.C. SECTION 1350)**




In
      connection with the Quarterly Report of DAIRY FRESH FARMS INC. (the "Company")
      on Form 10-QSB for the period ending June 30, 2007 as filed with the Securities
      and Exchange Commission on the date hereof (the "Report"), I, Don Paterson,
      Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C.
      § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
      2002, that:





(1)  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934, as amended; and




(2)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.


By
                    /s/Don
                      PatersonDon
                                  PatersonPrincipal
                                  Accounting
                                  Officer
  Date:
              August 14, 2007
Exhibit
        32.2
 CERTIFICATION
        PURSUANT TO
 18
        U.S.C.
        ss.1350, AS ADOPTED PURSUANT TO
 SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002
 
 Solely
        for the purposes of complying with, and the extent required by 18 U.S.C.
        1350,
        as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the
        undersigned certifies, in his capacity as the Chief Financial Officer of
        Integral Technologies, Inc., that, to his knowledge, the annual report of
        the
        company on Form 10-KSB for the period ended June 30, 2007, fully complies
        with
        the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
        of
        1934 and that the information contained in the report fairly presents, in
        all
        material respects, the company’s financial condition and results of
        operations.
  September
                  28, 2007/s/
                  William A. InceWilliam A. Ince,
                  Chief Financial Officer
# C_2016378EN.01000101.xml

| 14.10.2016 | EN | Official Journal of the European Union | C 378/1 |
| --- | --- | --- | --- |

14.10.2016

EN

Official Journal of the European Union

C 378/1

---

COUNCIL DECISION

of 11 October 2016

adopting the Council’s position on draft amending budget No 3 of the European Union for the financial year 2016

(2016/C 378/01)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 314 thereof, in conjunction with the Treaty establishing the European Atomic Energy Community, and in particular Article 106a thereof,

Having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (1) and in particular Article 41 thereof,

1

Whereas:

| — | the Union’s budget for the financial year 2016 was definitively adopted on 25 November 2015 (2) |
| --- | --- |

—

the Union’s budget for the financial year 2016 was definitively adopted on 25 November 2015 (2)

2

| — | on 30 June 2016, the Commission submitted a proposal containing draft amending budget No 3 to the general budget for the financial year 2016, |
| --- | --- |

—

on 30 June 2016, the Commission submitted a proposal containing draft amending budget No 3 to the general budget for the financial year 2016,

HAS DECIDED AS FOLLOWS:

Sole Article

The Council’s position on draft amending budget No 3 of the European Union for the financial year 2016 was adopted on 11 October 2016.

The full text can be accessed for consultation or downloading on the Council’s website: http://www.consilium.europa.eu

Done at Luxembourg, 11 October 2016.

For the Council

The President

P. KAŽIMÍR

---

(1)  OJ L 298, 26.10.2012, p. 1.

1

(2)  OJ L 48, 24.2.2016, p. 1.

2

---
**Exhibit 32.1**

 

**Certification Pursuant To18 U.S.C. Section 1350As Adopted Pursuant ToSection 906 of the Sarbanes-Oxley Act of 2002**

 

In connection with theQuarterly Report of Hospira, Inc. (the “Company”) on Form 10-Q forthe period ended September 30, 2008 as filed with the Securities andExchange Commission (the “Report”), I, Christopher B. Begley, Chairman andChief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350,as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fullycomplies with the requirements of section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

(2) The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

 
| /s/  CHRISTOPHER  B. BEGLEY |   |
|---------------------------------------|--------|
|                                  |
| Christopher  B. Begley                |
| Chairman  and Chief Executive Officer |
| November 5,  2008                |

 

1

----
KOHNEN v. EATON CORP.

No. COA03-798.

Court of Appeals of North Carolina.

Filed July 6, 2004.

Certification Date July 26, 2004.

Case reported without published opinion. Affirmed.
**EXHIBIT 32.1**

**CERTIFICATIONS PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

                Inconnection with the Quarterly Report of National Beef Packing Company, LLC (theCompany) on Form 10-Q for the period ended February 28, 2009 as filed with theSecurities and Exchange Commission on the date hereof (the Report), I, John R.Miller, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that: 

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934, as amended; and 

     

(2) Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

|   |   |                                    |
|--------|--------|-----------------------------------------|
| By:    |   | /s/ John R. Miller                      |
|   |   |                                    |
|   |   | John R. Miller*Chief Executive Officer* |

 

Date:April 15, 2009
Exhibit 32.1



QUADRAMED CORPORATION

SECTION 1350 CERTIFICATIONS



In connection with this Annual Report on Form 10-K of QuadraMed Corporation for the period ended December 31, 2008, I, Keith B. Hagen, Chief Executive Officer of QuadraMed Corporation, hereby certify pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my best knowledge:



|1. | This Form 10-K for the period ended December 31, 2008 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



|2. | The information contained in this Form 10-K for the period ended December 31, 2008 fairly presents, in all material respects, the financial condition and results of operations
of QuadraMed Corporation.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |  |  |                        
|-------------------- |  |  |  | -----------------------
|Date: March 10, 2009 |  |  |  | /s/ Keith B. Hagen     
|                     |  |  |  | Keith B. Hagen         
|                     |  |  |  | Chief Executive Officer
The world’s largest WATERFALL is in the OCEAN

Warm water
loses heat
to atmosphere

Greenlanc and sinks

Warmer surface waters flow northward

T Denser, cold
water flows
over the ridge

=
Ns
&
a
x
.°]

Height of the
- Denmark Cataract
(11,500 feet)

Cold, dense water flows southward in a deep current

Height of the largest
- waterfall on land

Sea Floor (3,212 feet)
#### Dudley C. ERICSON, as Liquor Control Commissioner for the State of Minnesota, Appellant, v. UNITED STATES of America.

No. 14626.

United States Court of Appeals Eighth Circuit.

June 18, 1953.

J. A. A. Burnquist, Atty. Gen. of Minn., and Irving M. Frisch, Sp. Asst. Atty. Gen. of Minn., for appellant.

George E. MacKinnon, U. S. Atty., and Thomas J. Ryan, Sp. Asst. U. S. Atty., Minneapolis, Minn., for appellee.

PER CURIAM.

Appeal from District Court dismissed without prejudice, 102 F.Supp. 376, on stipulation of counsel for respective parties.
Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Physicians Formula Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2009, as filed with the Securities and Exchange Commission (the “Report”), I, Jeff Berry, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
§1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





The foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Report or as a separate disclosure document.





Date: August 6, 2009





By:
/s/ Jeff BerryName:
Jeff BerryTitle:
Interim Chief Financial Officer





A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906,
has been provided to Physicians Formula Holdings, Inc. and will be retained by Physicians Formula Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5043 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5043

      To extend the temporary suspension of duty on Phenmedipham.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 17, 2008

  Mr. Costa introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on Phenmedipham.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PHENMEDIPHAM.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended--
            (1) in heading 9902.13.76, by striking the date in the 
        effective period column and inserting ``12/31/2011''; and
            (2) by striking heading 9902.31.13.
    (b) Effective Date.--The amendment made by subsection (a)(1) 
applies to goods entered, or withdrawn from warehouse for consumption, 
on or after the 15th day after the date of the enactment of this Act.
                                 <all>
```
ways to be a 

TRACK THE TIDES

6 WATCH FOR 

WHALES

MONITOR MARINE

DEBRIS

Pitch in at a local marine 

sanctuary or estuarine research 

reserve.

FIGHT 

HARMFUL 

ALGAL BLOOMS

BE A SANCTUARY 

STEWARD

GEOCACHE FOR 

A GOOD CAUSE

Citizen 

Scientist Share your whale sigh�ngs 

so scien�sts can track their 

popula�on trends. 

Record the type and 

amount of debris on 

your beach to help 

scien�sts tackle the 

challenge of marine 

debris.

Gather field notes, photos, 

and GPS data at bench marks 

for loca�on and height data.

Collect water quality 

data that helps NOAA 

respond to harmful algal 

blooms.

oceanservice.noaa.gov/ci�zen-science

Report local water levels 

and flood impacts to help 

NOAA be�er understand 

and communicate about 

future floods.
SMITH BARNEY INTERMEDIATE MUNICIPAL FUND, INC.
                          10F-3 REPORT
              May 1, 1997 through October 31, 1997
                                

                                                       % of
               Trade                    Par       Purchase  Fund
% of
Issuer              Date Selling Dealer      Amount         Price
Assets    Issue

Cleveland Stadium Project     5/22/97   A.G. Edwards & Sons
$1,000,000     $93.939        1.09%     0.72%
5.25% due 11/15/2027

New York City G.O.  7/24/97   Siebert Branford Shank
700,000     95.816       0.76 3.57
5.25% due 8/1/2020

NYS Environmental Fac.   9/18/97   Merrill Lynch        1,000,000
98.97               0.21
5.000% due 6/15/2012

Mesquite, TX IDS PSF     10/1/97   Rauscher Pierce
1,000,000   98.45             1.00
EXHIBIT 32

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002

Solely for the purpose of complying with 18 U.S.C. §1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002,
each of the undersigned in his capacity as an officer of Fremont Michigan InsuraCorp, Inc. (the Company) hereby certifies, to such officers knowledge, that:



|1. | The accompanying Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2011 (the Report) fully complies with the requirements of
Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |                                                                                         
|------------------ |  | ----------------------------------------------------------------------------------------
|Date: May 16, 2011 |  | /s/ Richard E. Dunning                                                                  
|                   |  | Richard E. Dunning, President and Chief Executive Officer                               
|                   | 
|Date: May 16, 2011 |  | /s/ Kevin G. Kaastra                                                                    
|                   |  | Kevin G. Kaastra, Vice President of Finance (principal financial and accounting officer)

The foregoing certifications are
being furnished solely to accompany the Report pursuant to 18 U.S.C. §1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing
of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.



31
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [B-05-2022]

On February 16, 2022, AstraZeneca Pharmaceuticals, LP submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 99D, in Newark, Delaware.

                    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the                     **Federal Register**                     inviting public comment (87 FR 10771, February 25, 2022). On June 16, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.                

Dated: June 16, 2022.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2022-13290 Filed 6-21-22; 8:45 am]

BILLING CODE 3510-DS-P
<PAGE>


                                                                    Exhibit 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

         We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (Nos. 333-13143, 333-13717, 333-53139, 333-55878,
333-76674, 333-88652 and 333-111283) of Millennium Chemicals Inc. of our report
dated March 8, 2004 relating to the financial statements and financial statement
schedule, which appears in this Annual Report on Form 10-K.

/s/  PricewaterhouseCoopers LLP

PRICEWATERHOUSECOOPERS LLP
Florham Park, New Jersey
March 12, 2004